Does IMIQUIMOD Cause Malignant neoplasm progression? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Malignant neoplasm progression have been filed in association with IMIQUIMOD (Imiquimod). This represents 0.4% of all adverse event reports for IMIQUIMOD.
6
Reports of Malignant neoplasm progression with IMIQUIMOD
0.4%
of all IMIQUIMOD reports
1
Deaths
0
Hospitalizations
How Dangerous Is Malignant neoplasm progression From IMIQUIMOD?
Of the 6 reports, 1 (16.7%) resulted in death.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMIQUIMOD. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does IMIQUIMOD Cause?
Off label use (264)
Product use in unapproved indication (179)
Erythema (171)
Drug ineffective (123)
Fatigue (118)
Influenza like illness (101)
Pain (98)
Application site erythema (95)
Nausea (90)
Headache (79)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which IMIQUIMOD Alternatives Have Lower Malignant neoplasm progression Risk?
IMIQUIMOD vs IMITREX
IMIQUIMOD vs IMMUNE GLOBULIN NOS
IMIQUIMOD vs IMPLANON
IMIQUIMOD vs INAVOLISIB
IMIQUIMOD vs INCIVEK